JP2004527206A - Ｒｙｋタンパク質を使用する新脈管形成の調節方法 - Google Patents

Ｒｙｋタンパク質を使用する新脈管形成の調節方法 Download PDF

Info

Publication number
JP2004527206A
JP2004527206A JP2001582388A JP2001582388A JP2004527206A JP 2004527206 A JP2004527206 A JP 2004527206A JP 2001582388 A JP2001582388 A JP 2001582388A JP 2001582388 A JP2001582388 A JP 2001582388A JP 2004527206 A JP2004527206 A JP 2004527206A
Authority
JP
Japan
Prior art keywords
seq
protein
ryk
variant
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001582388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004527206A5 (es
Inventor
ロツニアク，ステイーブ
ドウボワ−ストリングフエロー，ナタリー・エイ
ゾロトレブ，アルヤ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of JP2004527206A publication Critical patent/JP2004527206A/ja
Publication of JP2004527206A5 publication Critical patent/JP2004527206A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2001582388A 2000-05-10 2001-05-09 Ｒｙｋタンパク質を使用する新脈管形成の調節方法 Pending JP2004527206A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56878300A 2000-05-10 2000-05-10
PCT/US2001/015043 WO2001085789A2 (en) 2000-05-10 2001-05-09 Extracellular domain of ryk protein for regulating angiogenesis

Publications (2)

Publication Number Publication Date
JP2004527206A true JP2004527206A (ja) 2004-09-09
JP2004527206A5 JP2004527206A5 (es) 2008-06-26

Family

ID=24272718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001582388A Pending JP2004527206A (ja) 2000-05-10 2001-05-09 Ｒｙｋタンパク質を使用する新脈管形成の調節方法

Country Status (13)

Country Link
EP (1) EP1287121A2 (es)
JP (1) JP2004527206A (es)
AR (1) AR028424A1 (es)
AU (1) AU2001261343A1 (es)
CA (1) CA2408349A1 (es)
CO (1) CO5300464A1 (es)
DO (1) DOP2001000164A (es)
EC (1) ECSP014068A (es)
GT (1) GT200100079A (es)
PE (1) PE20011218A1 (es)
SV (1) SV2002000442A (es)
UY (1) UY26696A1 (es)
WO (1) WO2001085789A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066087A2 (en) * 2002-02-06 2003-08-14 Developgen Aktiengesellschaft Für Entwicklungsbiologische Forschung Kinases involved in the regulation of energy homeostasis
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
DK3170005T3 (da) 2014-07-18 2019-07-08 Sanofi Sa Fremgangsmåde til forudsigelse af resultatet af en behandling med aflibercept hos en patient, der mistænkes for at lide af cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07506969A (ja) * 1992-05-11 1995-08-03 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ レセプタ型チロシンキナーゼ類似の分子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980701950A (ko) * 1994-12-23 1998-06-25 에드워드 에이. 맥더모 2세, 로이드 제이. 오울드 분석, 리셉터 단백질 및 리간드
DE69930662T2 (de) * 1998-06-11 2006-12-28 Astrazeneca Ab Humane rezeptortyrosinkinase
ATE406907T1 (de) * 1998-10-28 2008-09-15 Cornell Res Foundation Inc Methoden zur regulierung der angiogenese und vaskuläre integrität mittels trk rezeptor liganden bdnf, nt-3 und nt-4

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07506969A (ja) * 1992-05-11 1995-08-03 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ レセプタ型チロシンキナーゼ類似の分子

Also Published As

Publication number Publication date
AU2001261343A1 (en) 2001-11-20
GT200100079A (es) 2001-12-31
CO5300464A1 (es) 2003-07-31
SV2002000442A (es) 2002-07-03
ECSP014068A (es) 2002-02-25
AR028424A1 (es) 2003-05-07
WO2001085789A2 (en) 2001-11-15
WO2001085789A3 (en) 2002-05-16
PE20011218A1 (es) 2002-02-01
CA2408349A1 (en) 2001-11-15
EP1287121A2 (en) 2003-03-05
UY26696A1 (es) 2001-12-28
DOP2001000164A (es) 2002-05-15

Similar Documents

Publication Publication Date Title
JP5132008B2 (ja) 血管内皮増殖因子２
ES2281704T3 (es) Procedimientos y compuestos para inhibir el crecimiento de celulas neoplasicas.
KR100628697B1 (ko) 맥관 내피 성장인자 ｄ를 발현하는 발현 벡터와 셀라인,및 흑색종을 치료하는 방법
KR101012904B1 (ko) 안지오포이에틴-유사 단백질 3 ａｎｇｐｔｌ3을 함유하는조성물 및 이를 사용하는 방법
US7999072B2 (en) Mutated netrin-4, fragments thereof and their use as medicines
CA2354422A1 (en) Connective tissue growth factor fragments and methods and uses thereof
JP2007244388A (ja) ヒト血管内皮増殖因子２
AU2003205716A1 (en) FGFR agonists
WO2003063893A2 (en) Fgfr agonists
JP2004505619A (ja) 血管内皮増殖因子２
JP2002531127A (ja) 成長因子相同体ｚｖｅｇｆ３
US8420780B2 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
EP1332761A1 (en) Agonists of fibroblast growth factor receptors (FGFR)
DK1677734T3 (en) CYSTATIN C AS AN ANTAGONIST OF TGF AND PROCEDURES RELATED TO IT
JP2004527206A (ja) Ｒｙｋタンパク質を使用する新脈管形成の調節方法
US20040023864A1 (en) Method of regulating angiogenesis using ryk protein
AU2008256550B2 (en) VEGF-D mutants and their use
ES2290606T3 (es) Procedimientos y composiciones para la inhibicion del crecimiento celular neoplasico.
JP3989589B2 (ja) 血管細胞調節剤
WO1999040193A1 (en) Angiopoietin homolog zapo3, dna encoding it, and method of making it
EP2275437A1 (en) Polypeptide and pharmaceutical composition containing the polypeptide
WO2012088563A1 (en) Vegfr-2-specific forms of vegf-d and vegf-c and uses thereof
US20040086501A1 (en) Protein having activity as an angiogenesis modulator
JP2003047470A (ja) 新規な抗体及びその用途
MXPA97009243A (es) Factor de crecimiento endotelial vascular humano 2

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080509

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20081021

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101214

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110913